Cargando…
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
Biopharmaceutical classification system (BCS) class IV drugs (low-solubility low-permeability) are generally poor drug candidates, yet, ~5% of oral drugs on the market belong to this class. While solubility is often predictable, intestinal permeability is rather complicated and highly dependent on m...
Autores principales: | Markovic, Milica, Zur, Moran, Ragatsky, Inna, Cvijić, Sandra, Dahan, Arik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761534/ https://www.ncbi.nlm.nih.gov/pubmed/33276565 http://dx.doi.org/10.3390/pharmaceutics12121175 |
Ejemplares similares
-
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil
por: Markovic, Milica, et al.
Publicado: (2022) -
Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
por: Kaneko, Kenichi, et al.
Publicado: (2022) -
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin
por: Dahan, Arik, et al.
Publicado: (2021) -
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development
por: Markovic, Milica, et al.
Publicado: (2020) -
Preparation, Optimization and Characterization of Chitosan-coated Liposomes for Solubility Enhancement of Furosemide: A Model BCS IV Drug
por: Moslehi, Mohammad, et al.
Publicado: (2020)